MyMD Pharmaceuticals, Inc. logo

MyMD Pharmaceuticals, Inc.

NASDAQ:MYMD

Overview | Financials
Company Name MyMD Pharmaceuticals, Inc.
Symbol MYMD
Currency USD
Price 1.81
Market Cap 4,290,460
Dividend Yield 0%
52-week-range 1.75 - 63.9
Industry Biotechnology
Sector Healthcare
CEO Dr. Christopher C. Chapman Jr., M.D.
Website https://www.mymd.com

An error occurred while fetching data.

About MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other

Related Stocks

Daré Bioscience, Inc. logo

Daré Bioscience, Inc.

DARE

3.31 USD

Surrozen, Inc. logo

Surrozen, Inc.

SRZN

8.58 USD

Elevation Oncology, Inc. logo

Elevation Oncology, Inc.

ELEV

0.609 USD

Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.

EVLO

0.023 USD

Celcuity Inc. logo

Celcuity Inc.

CELC

14.98 USD

NRx Pharmaceuticals, Inc. logo

NRx Pharmaceuticals, Inc.

NRXP

1.72 USD

Financials

Numbers are in millions USD

Numbers are in millions USD